Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Nicotinamide phosphoribosyltransferase (NAmPRTase) (Nampt) (EC 2.4.2.12) (Pre-B-cell colony-enhancing factor 1 homolog) (PBEF) (Visfatin)

 NAMPT_MOUSE             Reviewed;         491 AA.
Q99KQ4; Q8C3B5; Q9JKM0;
05-JUL-2005, integrated into UniProtKB/Swiss-Prot.
01-JUN-2001, sequence version 1.
18-JUL-2018, entry version 146.
RecName: Full=Nicotinamide phosphoribosyltransferase;
Short=NAmPRTase;
Short=Nampt;
EC=2.4.2.12;
AltName: Full=Pre-B-cell colony-enhancing factor 1 homolog;
Short=PBEF;
AltName: Full=Visfatin;
Name=Nampt; Synonyms=Pbef1;
Mus musculus (Mouse).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
Muroidea; Muridae; Murinae; Mus; Mus.
NCBI_TaxID=10090;
[1]
NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, INDUCTION, SUBCELLULAR LOCATION,
CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND TISSUE
SPECIFICITY.
TISSUE=T-cell;
PubMed=12555668;
DOI=10.1002/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L;
Rongvaux A., Shea R.J., Mulks M.H., Gigot D., Urbain J., Leo O.,
Andris F.;
"Pre-B-cell colony-enhancing factor, whose expression is up-regulated
in activated lymphocytes, is a nicotinamide phosphoribosyltransferase,
a cytosolic enzyme involved in NAD biosynthesis.";
Eur. J. Immunol. 32:3225-3234(2002).
[2]
NUCLEOTIDE SEQUENCE [MRNA], BIOPHYSICOCHEMICAL PROPERTIES, AND
FUNCTION.
STRAIN=BALB/cJ; TISSUE=Liver;
PubMed=15381699; DOI=10.1074/jbc.M408388200;
Revollo J.R., Grimm A.A., Imai S.;
"The NAD biosynthesis pathway mediated by nicotinamide
phosphoribosyltransferase regulates Sir2 activity in mammalian
cells.";
J. Biol. Chem. 279:50754-50763(2004).
[3]
NUCLEOTIDE SEQUENCE [MRNA].
Samal B.B., Sun N., Sun Y.;
"Mus musculus pre-B-cell colony-enhancing factor (PBEF) mRNA.";
Submitted (FEB-2000) to the EMBL/GenBank/DDBJ databases.
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
STRAIN=Czech II, and FVB/N; TISSUE=Mammary tumor;
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[5]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-368.
STRAIN=C57BL/6J; TISSUE=Head;
PubMed=16141072; DOI=10.1126/science.1112014;
Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
Hayashizaki Y.;
"The transcriptional landscape of the mammalian genome.";
Science 309:1559-1563(2005).
[6]
FUNCTION, AND INDUCTION.
PubMed=19299583; DOI=10.1126/science.1171641;
Ramsey K.M., Yoshino J., Brace C.S., Abrassart D., Kobayashi Y.,
Marcheva B., Hong H.K., Chong J.L., Buhr E.D., Lee C., Takahashi J.S.,
Imai S., Bass J.;
"Circadian clock feedback cycle through NAMPT-mediated NAD+
biosynthesis.";
Science 324:651-654(2009).
[7]
FUNCTION.
PubMed=19286518; DOI=10.1126/science.1170803;
Nakahata Y., Sahar S., Astarita G., Kaluzova M., Sassone-Corsi P.;
"Circadian control of the NAD+ salvage pathway by CLOCK-SIRT1.";
Science 324:654-657(2009).
[8]
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Liver, Lung,
Pancreas, Spleen, and Testis;
PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
"A tissue-specific atlas of mouse protein phosphorylation and
expression.";
Cell 143:1174-1189(2010).
[9]
X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS), AND SUBUNIT.
PubMed=16783377; DOI=10.1038/nsmb1105;
Khan J.A., Tao X., Tong L.;
"Molecular basis for the inhibition of human NMPRTase, a novel target
for anticancer agents.";
Nat. Struct. Mol. Biol. 13:582-588(2006).
[10]
X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) IN COMPLEX WITH NICOTINAMIDE
MONONUCLEOTIDE, AND SUBUNIT.
PubMed=16783373; DOI=10.1038/nsmb1114;
Wang T., Zhang X., Bheda P., Revollo J.R., Imai S., Wolberger C.;
"Structure of Nampt/PBEF/visfatin, a mammalian NAD+ biosynthetic
enzyme.";
Nat. Struct. Mol. Biol. 13:661-662(2006).
-!- FUNCTION: The secreted form behaves both as a cytokine with
immunomodulating properties and an adipokine with anti-diabetic
properties, it has no enzymatic activity, partly because of lack
of activation by ATP, which has a low level in extracellular space
and plasma (By similarity). Catalyzes the condensation of
nicotinamide with 5-phosphoribosyl-1-pyrophosphate to yield
nicotinamide mononucleotide, an intermediate in the biosynthesis
of NAD. It is the rate limiting component in the mammalian NAD
biosynthesis pathway. Plays a role in the modulation of circadian
clock function. NAMPT-dependent oscillatory production of NAD
regulates oscillation of clock target gene expression by releasing
the core clock component: CLOCK-ARNTL/BMAL1 heterodimer from NAD-
dependent SIRT1-mediated suppression.
{ECO:0000250|UniProtKB:P43490, ECO:0000269|PubMed:12555668,
ECO:0000269|PubMed:15381699, ECO:0000269|PubMed:19286518,
ECO:0000269|PubMed:19299583}.
-!- CATALYTIC ACTIVITY: Nicotinamide D-ribonucleotide + diphosphate =
nicotinamide + 5-phospho-alpha-D-ribose 1-diphosphate.
{ECO:0000269|PubMed:12555668}.
-!- BIOPHYSICOCHEMICAL PROPERTIES:
Kinetic parameters:
KM=0.92 uM for nicotinamide {ECO:0000269|PubMed:12555668,
ECO:0000269|PubMed:15381699};
Vmax=0.021 umol/min/mg enzyme {ECO:0000269|PubMed:12555668,
ECO:0000269|PubMed:15381699};
-!- PATHWAY: Cofactor biosynthesis; NAD(+) biosynthesis; nicotinamide
D-ribonucleotide from 5-phospho-alpha-D-ribose 1-diphosphate and
nicotinamide: step 1/1.
-!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:16783373,
ECO:0000269|PubMed:16783377}.
-!- INTERACTION:
Self; NbExp=4; IntAct=EBI-8316571, EBI-8316571;
-!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P43490}.
Cytoplasm {ECO:0000269|PubMed:12555668}. Secreted
{ECO:0000250|UniProtKB:P43490}. Note=Under non-inflammatory
conditions, visfatin predominantly exhibits a granular pattern
within the nucleus. Secreted by endothelial cells upon IL-1beta
stimulation. Abundantly secreted in milk, reaching 100-fold higher
concentrations compared to maternal serum.
{ECO:0000250|UniProtKB:P43490}.
-!- TISSUE SPECIFICITY: Ubiquitously expressed in lymphoid and non-
lymphoid tissues. {ECO:0000269|PubMed:12555668}.
-!- INDUCTION: Expression shows a diurnal pattern of oscillation
across the 24-hour light-dark cycle in liver, with a reduction in
levels before the onset of the dark period (at protein level).
Expression shows a diurnal pattern of oscillation in white adipose
tissue (WAT), peaking at the beginning of the dark period. Up-
regulated during polyclonal immune responses.
{ECO:0000269|PubMed:12555668, ECO:0000269|PubMed:19299583}.
-!- SIMILARITY: Belongs to the NAPRTase family. {ECO:0000305}.
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
-----------------------------------------------------------------------
EMBL; AY679720; AAT72933.1; -; mRNA.
EMBL; AF234625; AAF43208.1; -; mRNA.
EMBL; BC004059; AAH04059.1; -; mRNA.
EMBL; BC018358; AAH18358.1; -; mRNA.
EMBL; AK086415; BAC39664.1; -; mRNA.
CCDS; CCDS25871.1; -.
RefSeq; NP_067499.2; NM_021524.2.
UniGene; Mm.202727; -.
PDB; 2GVL; X-ray; 2.10 A; A/B=1-491.
PDB; 2H3B; X-ray; 1.95 A; A/B=1-491.
PDB; 2H3D; X-ray; 2.10 A; A/B=1-491.
PDBsum; 2GVL; -.
PDBsum; 2H3B; -.
PDBsum; 2H3D; -.
ProteinModelPortal; Q99KQ4; -.
SMR; Q99KQ4; -.
DIP; DIP-29217N; -.
IntAct; Q99KQ4; 3.
MINT; Q99KQ4; -.
STRING; 10090.ENSMUSP00000020886; -.
BindingDB; Q99KQ4; -.
ChEMBL; CHEMBL3259474; -.
iPTMnet; Q99KQ4; -.
PhosphoSitePlus; Q99KQ4; -.
SwissPalm; Q99KQ4; -.
EPD; Q99KQ4; -.
MaxQB; Q99KQ4; -.
PaxDb; Q99KQ4; -.
PeptideAtlas; Q99KQ4; -.
PRIDE; Q99KQ4; -.
Ensembl; ENSMUST00000020886; ENSMUSP00000020886; ENSMUSG00000020572.
GeneID; 59027; -.
KEGG; mmu:59027; -.
UCSC; uc007nif.2; mouse.
CTD; 10135; -.
MGI; MGI:1929865; Nampt.
eggNOG; ENOG410IEB2; Eukaryota.
eggNOG; COG1488; LUCA.
GeneTree; ENSGT00390000006647; -.
HOGENOM; HOG000216546; -.
HOVERGEN; HBG000336; -.
InParanoid; Q99KQ4; -.
KO; K03462; -.
OMA; VWYPITV; -.
OrthoDB; EOG091G04ZB; -.
PhylomeDB; Q99KQ4; -.
TreeFam; TF333530; -.
BRENDA; 2.4.2.12; 3474.
Reactome; R-MMU-197264; Nicotinamide salvaging.
SABIO-RK; Q99KQ4; -.
UniPathway; UPA00253; UER00890.
ChiTaRS; Nampt; mouse.
EvolutionaryTrace; Q99KQ4; -.
PRO; PR:Q99KQ4; -.
Proteomes; UP000000589; Chromosome 12.
Bgee; ENSMUSG00000020572; -.
CleanEx; MM_NAMPT; -.
ExpressionAtlas; Q99KQ4; baseline and differential.
Genevisible; Q99KQ4; MM.
GO; GO:0030054; C:cell junction; ISO:MGI.
GO; GO:0005737; C:cytoplasm; IDA:MGI.
GO; GO:0005829; C:cytosol; TAS:Reactome.
GO; GO:0005615; C:extracellular space; IEA:UniProtKB-KW.
GO; GO:0016607; C:nuclear speck; ISO:MGI.
GO; GO:0005634; C:nucleus; ISO:MGI.
GO; GO:0005125; F:cytokine activity; ISO:MGI.
GO; GO:0008144; F:drug binding; ISO:MGI.
GO; GO:0042802; F:identical protein binding; IPI:IntAct.
GO; GO:0047280; F:nicotinamide phosphoribosyltransferase activity; IDA:MGI.
GO; GO:0004514; F:nicotinate-nucleotide diphosphorylase (carboxylating) activity; IEA:InterPro.
GO; GO:0042803; F:protein homodimerization activity; ISO:MGI.
GO; GO:0032922; P:circadian regulation of gene expression; IMP:UniProtKB.
GO; GO:0007623; P:circadian rhythm; IEP:UniProtKB.
GO; GO:0007565; P:female pregnancy; IEA:Ensembl.
GO; GO:0009435; P:NAD biosynthetic process; IDA:MGI.
GO; GO:0051770; P:positive regulation of nitric-oxide synthase biosynthetic process; ISO:MGI.
GO; GO:0048661; P:positive regulation of smooth muscle cell proliferation; ISO:MGI.
GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:MGI.
GO; GO:0014070; P:response to organic cyclic compound; IEA:Ensembl.
CDD; cd01569; PBEF_like; 1.
Gene3D; 3.20.20.70; -; 1.
InterPro; IPR013785; Aldolase_TIM.
InterPro; IPR007229; Nic_PRibTrfase-Fam.
InterPro; IPR016471; Nicotinamide_PRibTrfase.
InterPro; IPR036068; Nicotinate_pribotase_like_C.
PANTHER; PTHR43816; PTHR43816; 1.
Pfam; PF04095; NAPRTase; 1.
PIRSF; PIRSF005943; NMPRT; 1.
SUPFAM; SSF51690; SSF51690; 1.
1: Evidence at protein level;
3D-structure; Acetylation; Biological rhythms; Complete proteome;
Cytokine; Cytoplasm; Glycosyltransferase; Nucleus; Phosphoprotein;
Pyridine nucleotide biosynthesis; Reference proteome; Secreted;
Transferase.
CHAIN 1 491 Nicotinamide phosphoribosyltransferase.
/FTId=PRO_0000205864.
REGION 311 313 Nicotinamide ribonucleotide binding.
REGION 353 354 Nicotinamide ribonucleotide binding.
BINDING 196 196 Diphosphate. {ECO:0000250}.
BINDING 219 219 Nicotinamide ribonucleotide.
BINDING 247 247 Diphosphate. {ECO:0000250}.
BINDING 311 311 Diphosphate. {ECO:0000250}.
BINDING 384 384 Nicotinamide ribonucleotide; via amide
nitrogen.
BINDING 392 392 Nicotinamide ribonucleotide.
MOD_RES 1 1 N-acetylmethionine.
{ECO:0000250|UniProtKB:P43490}.
MOD_RES 188 188 Phosphotyrosine.
{ECO:0000250|UniProtKB:P43490}.
MOD_RES 472 472 Phosphoserine.
{ECO:0000250|UniProtKB:P43490}.
CONFLICT 170 170 K -> R (in Ref. 3; AAF43208).
{ECO:0000305}.
CONFLICT 193 193 F -> S (in Ref. 3; AAF43208).
{ECO:0000305}.
CONFLICT 215 215 F -> L (in Ref. 3; AAF43208).
{ECO:0000305}.
HELIX 11 13 {ECO:0000244|PDB:2H3B}.
STRAND 14 16 {ECO:0000244|PDB:2H3D}.
HELIX 17 24 {ECO:0000244|PDB:2H3B}.
STRAND 30 39 {ECO:0000244|PDB:2H3B}.
STRAND 56 59 {ECO:0000244|PDB:2H3B}.
HELIX 62 69 {ECO:0000244|PDB:2H3B}.
HELIX 77 91 {ECO:0000244|PDB:2H3B}.
HELIX 98 108 {ECO:0000244|PDB:2H3B}.
STRAND 114 118 {ECO:0000244|PDB:2H3B}.
STRAND 123 126 {ECO:0000244|PDB:2H3B}.
STRAND 129 138 {ECO:0000244|PDB:2H3B}.
HELIX 139 143 {ECO:0000244|PDB:2H3B}.
HELIX 144 147 {ECO:0000244|PDB:2H3B}.
HELIX 149 153 {ECO:0000244|PDB:2H3B}.
HELIX 156 180 {ECO:0000244|PDB:2H3B}.
HELIX 186 188 {ECO:0000244|PDB:2H3B}.
STRAND 189 192 {ECO:0000244|PDB:2H3B}.
TURN 195 197 {ECO:0000244|PDB:2H3B}.
HELIX 201 211 {ECO:0000244|PDB:2H3B}.
TURN 212 214 {ECO:0000244|PDB:2H3B}.
STRAND 216 219 {ECO:0000244|PDB:2H3B}.
HELIX 222 230 {ECO:0000244|PDB:2H3B}.
STRAND 234 236 {ECO:0000244|PDB:2H3D}.
STRAND 238 240 {ECO:0000244|PDB:2H3B}.
HELIX 247 251 {ECO:0000244|PDB:2H3B}.
HELIX 255 257 {ECO:0000244|PDB:2H3B}.
HELIX 258 268 {ECO:0000244|PDB:2H3B}.
STRAND 270 272 {ECO:0000244|PDB:2H3B}.
STRAND 274 277 {ECO:0000244|PDB:2H3B}.
HELIX 283 288 {ECO:0000244|PDB:2H3B}.
HELIX 289 294 {ECO:0000244|PDB:2H3B}.
HELIX 296 299 {ECO:0000244|PDB:2H3B}.
STRAND 308 311 {ECO:0000244|PDB:2H3B}.
HELIX 317 331 {ECO:0000244|PDB:2H3B}.
STRAND 348 352 {ECO:0000244|PDB:2H3B}.
HELIX 358 370 {ECO:0000244|PDB:2H3B}.
HELIX 375 377 {ECO:0000244|PDB:2H3B}.
STRAND 378 383 {ECO:0000244|PDB:2H3B}.
HELIX 384 387 {ECO:0000244|PDB:2H3B}.
TURN 392 396 {ECO:0000244|PDB:2H3B}.
STRAND 397 406 {ECO:0000244|PDB:2H3B}.
STRAND 409 412 {ECO:0000244|PDB:2H3B}.
HELIX 421 423 {ECO:0000244|PDB:2H3B}.
STRAND 431 434 {ECO:0000244|PDB:2H3B}.
STRAND 440 443 {ECO:0000244|PDB:2H3B}.
HELIX 447 450 {ECO:0000244|PDB:2H3B}.
STRAND 452 454 {ECO:0000244|PDB:2GVL}.
STRAND 459 463 {ECO:0000244|PDB:2H3B}.
HELIX 473 479 {ECO:0000244|PDB:2H3B}.
SEQUENCE 491 AA; 55447 MW; D3E522A1841297E6 CRC64;
MNAAAEAEFN ILLATDSYKV THYKQYPPNT SKVYSYFECR EKKTENSKVR KVKYEETVFY
GLQYILNKYL KGKVVTKEKI QEAKEVYREH FQDDVFNERG WNYILEKYDG HLPIEVKAVP
EGSVIPRGNV LFTVENTDPE CYWLTNWIET ILVQSWYPIT VATNSREQKK ILAKYLLETS
GNLDGLEYKL HDFGYRGVSS QETAGIGASA HLVNFKGTDT VAGIALIKKY YGTKDPVPGY
SVPAAEHSTI TAWGKDHEKD AFEHIVTQFS SVPVSVVSDS YDIYNACEKI WGEDLRHLIV
SRSTEAPLII RPDSGNPLDT VLKVLDILGK KFPVTENSKG YKLLPPYLRV IQGDGVDINT
LQEIVEGMKQ KKWSIENVSF GSGGALLQKL TRDLLNCSFK CSYVVTNGLG VNVFKDPVAD
PNKRSKKGRL SLHRTPAGNF VTLEEGKGDL EEYGHDLLHT VFKNGKVTKS YSFDEVRKNA
QLNIEQDVAP H


Related products :

Catalog number Product name Quantity
U0638p CLIA NAmPRTase,Nampt,NAMPT,Nicotinamide phosphoribosyltransferase,PBEF,PBEF1,Pig,Pre-B-cell colony-enhancing factor 1 homolog,Sus scrofa,Visfatin 96T
E0638p ELISA NAmPRTase,Nampt,NAMPT,Nicotinamide phosphoribosyltransferase,PBEF,PBEF1,Pig,Pre-B-cell colony-enhancing factor 1 homolog,Sus scrofa,Visfatin 96T
E0638p ELISA kit NAmPRTase,Nampt,NAMPT,Nicotinamide phosphoribosyltransferase,PBEF,PBEF1,Pig,Pre-B-cell colony-enhancing factor 1 homolog,Sus scrofa,Visfatin 96T
E0638r ELISA kit NAmPRTase,Nampt,Nampt,Nicotinamide phosphoribosyltransferase,PBEF,Pbef1,Pre-B-cell colony-enhancing factor 1 homolog,Rat,Rattus norvegicus,Visfatin 96T
E0638r ELISA NAmPRTase,Nampt,Nampt,Nicotinamide phosphoribosyltransferase,PBEF,Pbef1,Pre-B-cell colony-enhancing factor 1 homolog,Rat,Rattus norvegicus,Visfatin 96T
E0638m ELISA kit Mouse,Mus musculus,NAmPRTase,Nampt,Nampt,Nicotinamide phosphoribosyltransferase,PBEF,Pbef1,Pre-B-cell colony-enhancing factor 1 homolog,Visfatin 96T
E0638m ELISA Mouse,Mus musculus,NAmPRTase,Nampt,Nampt,Nicotinamide phosphoribosyltransferase,PBEF,Pbef1,Pre-B-cell colony-enhancing factor 1 homolog,Visfatin 96T
U0638m CLIA Mouse,Mus musculus,NAmPRTase,Nampt,Nampt,Nicotinamide phosphoribosyltransferase,PBEF,Pbef1,Pre-B-cell colony-enhancing factor 1 homolog,Visfatin 96T
U0638r CLIA NAmPRTase,Nampt,Nampt,Nicotinamide phosphoribosyltransferase,PBEF,Pbef1,Pre-B-cell colony-enhancing factor 1 homolog,Rat,Rattus norvegicus,Visfatin 96T
U0638h CLIA Homo sapiens,Human,NAmPRTase,Nampt,NAMPT,Nicotinamide phosphoribosyltransferase,PBEF,PBEF1,Pre-B cell-enhancing factor,Pre-B-cell colony-enhancing factor 1,Visfatin 96T
E0638h ELISA Homo sapiens,Human,NAmPRTase,Nampt,NAMPT,Nicotinamide phosphoribosyltransferase,PBEF,PBEF1,Pre-B cell-enhancing factor,Pre-B-cell colony-enhancing factor 1,Visfatin 96T
E0638h ELISA kit Homo sapiens,Human,NAmPRTase,Nampt,NAMPT,Nicotinamide phosphoribosyltransferase,PBEF,PBEF1,Pre-B cell-enhancing factor,Pre-B-cell colony-enhancing factor 1,Visfatin 96T
18-003-44285 Nicotinamide phosphoribosyltransferase - EC 2.4.2.12; NAmPRTase; Nampt; Pre-B cell-enhancing factor; Pre-B-cell colony-enhancing factor 1; Visfatin Polyclonal 0.1 mg Protein A
18-003-43733 Nicotinamide phosphoribosyltransferase - EC 2.4.2.12; NAmPRTase; Nampt; Pre-B cell-enhancing factor; Pre-B-cell colony-enhancing factor 1; Visfatin Polyclonal 0.1 mg Protein A
CP22 Recombinant Human Pre-B-Cell Colony-Enhancing Factor 1 per PBEF per Visfatin (N-6His) 10ug
10-002-38089 Visfatin. (1-511aa). Mouse. His-tagged. Recombinant. E Coli - Pre-B-cell colony-enhancing factor 1; N_A N_A 0.5 mg
10-002-38089 Visfatin. (1-511aa). Mouse. His-tagged. Recombinant. E Coli - Pre-B-cell colony-enhancing factor 1; N_A N_A 0.1 mg
100-363 Visfatin Human Host: E. coli NAMPT; VF; PBEF; PBEF1; VISFATIN; 1110035O14Rik 25
100-363 Visfatin, Host: E. coli, Species: Human, Synonyms: NAMPT; VF; PBEF; PBEF1; VISFATIN; 1110035O14Rik 25 ug
gen9265 NAMPT_MOUSE Pre-B-cell colony-enhancing factor 1 homolog ELISA tesk kit 1
gen9281 NAMPT_RAT Pre-B-cell colony-enhancing factor 1 homolog ELISA tesk kit 1
gen9273 NAMPT_PIG Pre-B-cell colony-enhancing factor 1 homolog ELISA tesk kit 1
DEEIHVIS1 Visfatin (Nampt, PBEF), Species mouse,rat 96 tests
GWB-AXR245 Nampt (Visfatin PBEF) (mouse rat) Intracellular ELISA Kit
GWB-AXR244 Nampt (Visfatin PBEF) (human) Intracellular ELISA Kit


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur